Should We Continue Assessing Glomerular Filtration Rate with the Cockroft–Gault Formula in NOAC-Treated Patients? The Magnitude of the Problem

Should We Continue Assessing Glomerular Filtration Rate with the Cockroft–Gault Formula in NOAC-Treated Patients? The Magnitude of the Problem

Despite the proven superiority of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) over the Cockcroft–Gault (CG) formula, current guidelines recommend the latter to assess renal function in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs). To assess the relat...

Full description

Bibliographic Details
Main Authors: Roberto Cemin, Luisa Foco, Carmine Zoccali, Raffaele De Caterina
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Journal of Clinical Medicine
Subjects:
atrial fibrillation
non-vitamin K antagonist oral anticoagulants
renal function
reclassification
Online Access:https://www.mdpi.com/2077-0383/9/6/1893

Internet

https://www.mdpi.com/2077-0383/9/6/1893

Similar Items